You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 6, August 10, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Medical Ethics
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Patient-Physician Communication
 •Alert me on articles by topic

HIV Testing Without Consent in Critically Ill Patients

Scott D. Halpern, MD, PhD, MBioethics

JAMA. 2005;294:734-737.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Consider the following 3 newly admitted patients. The first patient has marked hypoxemia requiring mechanical ventilation and is found to have nonspecific, bilateral, alveolar infiltrates on chest radiography. The second patient has had a severe change in mental status and on brain imaging has an enhancing lesion exerting a mass effect. The third patient has high fevers, ventilator-dependent respiratory failure, and diffuse nodular infiltrates on chest radiography, with negative blood, urine, and sputum cultures after 48 hours.

In each of these cases, the next steps in physicians’ diagnostic and therapeutic algorithms could be usefully informed by knowledge of the patients’ immunocompetency. Knowing that these patients had recently used immunosuppressive therapies, or were infected with the human immunodeficiency virus (HIV), would substantially increase the probabilities of Pneumocystis jiroveci pneumonia in the first patient, toxoplasmosis in the second patient, and disseminated fungal or mycobacterial infections in . . . [Full Text of this Article]

Current Policies

Author Affiliations: Department of Medicine, Center for Clinical Epidemiology and Biostatistics, Center for Education and Research on Therapeutics, and Center for Bioethics, University of Pennsylvania School of Medicine, Philadelphia.


RELATED LETTERS

Consent and HIV Testing in Critically Ill Patients
Virginio Bonito, Maria Simonetta Spada, Francesco Locati, Gianmariano Marchesi, Marco Salmoiraghi, and Sandro Spinsanti
JAMA. 2006;295(1):38.
EXTRACT | FULL TEXT  

Consent and HIV Testing in Critically Ill Patients—Reply
Scott D. Halpern
JAMA. 2006;295(1):38.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.